Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGINTERVENTIONAL

Study of Transcranial Direct Current Stimulation to Treat Epilepsy

Pilot Study of Transcranial Direct Current Stimulation (tDCS) to Treat Epilepsy

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The purpose of this research is to see to what extent electrical stimulation applied to the scalp (transcranial direct current stimulation or tDCS) can reduce the number and intensity of epileptic seizures.

Who May Be Eligible (Plain English)

Inclusion Criteria - Clinical diagnosis of generalized onset or focal epilepsy or sleep-related epileptic encephalopathy. - Estimated to have at least 2 countable seizures per month or spike-wave index ≥50%. - Has not had control with at least 2 anti-seizure medicines. - Able to maintain a constant medication for duration of the study (rescue meds allowed). - Subject or legally authorized representative is able to understand consent and keep a seizure diary in English. Who Should NOT Join This Trial: - A disease likely to progress over course of the study. - Psychogenic non-epileptic seizures. - Suicide attempt or psychiatric hospitalization past 2 years. - A skin condition interfering with scalp electrodes or allergy to silver. - Women will verify not pregnant, and if applicable, have a serum pregnancy test. - Implanted devices (e.g. pacemakers)-except VNS, which is allowed. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria * Clinical diagnosis of generalized onset or focal epilepsy or sleep-related epileptic encephalopathy. * Estimated to have at least 2 countable seizures per month or spike-wave index ≥50%. * Has not had control with at least 2 anti-seizure medicines. * Able to maintain a constant medication for duration of the study (rescue meds allowed). * Subject or legally authorized representative is able to understand consent and keep a seizure diary in English. Exclusion Criteria: * A disease likely to progress over course of the study. * Psychogenic non-epileptic seizures. * Suicide attempt or psychiatric hospitalization past 2 years. * A skin condition interfering with scalp electrodes or allergy to silver. * Women will verify not pregnant, and if applicable, have a serum pregnancy test. * Implanted devices (e.g. pacemakers)-except VNS, which is allowed.

Treatments Being Tested

DEVICE

ActivaDose II 0.1 mA transcranial direct current stimulation (tDCS)

Stimulation setting 0.1 mA daily for a 2-month period. Each daily treatment will last for approximately 30 minutes.

DEVICE

ActivaDose II 2.0 mA transcranial direct current stimulation (tDCS)

Stimulation setting 2.0 mA daily for a 2-month period. A Each daily treatment will last for approximately 30 minutes.

Locations (1)

Mayo Clinic Minnesota
Rochester, Minnesota, United States